Daniel M. Geynisman, MD
Department of Hematology/Oncology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, USA
Dr. Geynisman is an Assistant Professor in the Department of Hematology/Oncology at Fox Chase Cancer Center. His clinical work focuses on urological malignancies including bladder, kidney, prostate, penile and testicular cancers. His research interests focus on health outcomes evaluations in urologic malignancies, quality improvement in oncology, the cost and utilization of novel cancer therapies as well as new drug development for genitourinary malignancies. He has collaborated on work that has included studies of adherence to oral anticancer medications in renal cell carcinoma, breast and prostate cancer, utilization and costs of oral drugs in renal cell carcinoma and reviews of cost effectiveness analyses in oral anticancer medications. In addition he is an active investigator on a number of past and ongoing clinical trials, with a particular focus in bladder and kidney cancer. He serves on the NCCN guideline panel for testicular cancers and is an assistant editor for Urologic Oncology.
Dr. Geynisman earned his medical degree from the University Of Pittsburgh School Of Medicine and completed a residency in internal medicine at the University Of Pittsburgh Medical Center, serving an additional year as chief resident. He then went on to a fellowship in Hematology/Oncology at the University of Chicago, serving as a chief fellow in his final year of training.
Terms of Appointment: Sep 2019 - Oct 2021